Silk Road Medical shares are trading lower after JP Morgan downgraded the stock from Overweight to Neutral and lowered its price target from $50 to $28.
Portfolio Pulse from Benzinga Newsdesk
JP Morgan has downgraded Silk Road Medical's stock from Overweight to Neutral and reduced its price target from $50 to $28. This has led to a decrease in the company's share price.
July 12, 2023 | 11:29 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Silk Road Medical's stock has been downgraded by JP Morgan, leading to a decrease in its share price. The price target has also been lowered from $50 to $28.
JP Morgan's downgrade of Silk Road Medical's stock and the lowering of its price target has led to a decrease in the company's share price. This indicates a negative outlook for the company's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100